High-throughput single-base mismatch detection for genotyping of UDP-glucuronosyltransferase (UGT1A1) with probe capture assay coupled with modified allele-specific primer extension reaction (MASPER)

Journal of Clinical Laboratory Analysis

Volumn 24, Issue 2, 2010, Pages 85-91

  Kisaki, Osamu ^a   Kato, Seiji ^a   Shinohara, Kohei ^a   Hiura, Hisahide ^a   Samori, Tomohiro ^a   Sato, Hiroshi ^b  

^a Japan Clinical Laboratories Inc   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Allele specific primer; Plate hybridization; Single base mutation; UGT1A1

Indexed keywords

GENOMIC DNA; GLUCURONOSYLTRANSFERASE 1A1; HORSERADISH PEROXIDASE; PRIMER DNA; STREPTAVIDIN;

ARTICLE; BASE MISPAIRING; DNA EXTRACTION; ENZYMATIC ASSAY; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; MODIFIED ALLELE SPECIFIC PRIMER EXTENSION REACTION; POLYMERASE CHAIN REACTION; PROBE CAPTURE ASSAY; REPRODUCIBILITY; SENSITIVITY ANALYSIS;

BASE PAIR MISMATCH; CRIGLER-NAJJAR SYNDROME; DNA MUTATIONAL ANALYSIS; GENOTYPE; GILBERT DISEASE; GLUCURONOSYLTRANSFERASE; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; NUCLEIC ACID HYBRIDIZATION; POINT MUTATION; REPRODUCIBILITY OF RESULTS;

ARMORACIA RUSTICANA;

EID: 77951532118     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20359     Document Type: Article

References (32)

1. Kruglyak L. The use of a genetic map of biallelic markers in linkage studies. Nat Genet 1997;17:21-24. (Pubitemid 27377527)
2. Gu Z, Hillier L, Kwok PY. Single nucleotide polymorphism hunting in cyberspace. Hum Mutat 1998;12:221-225. (Pubitemid 28418890)
3. Nebert DW. Pharmacogenetics and pharmacogenomics: Why is this relevant to the clinical geneticist? Clin Genet 1999;56:247-258.
4. McCarthy JJ, Hilfiker R. The use of single-nucleotide polymorphism maps in pharmacogenomics. Nat Biotechnol 2000;18:505-508. (Pubitemid 30313953)
5. See D, Kanazin V, Talbert H, Blake T. Electrophoretic detection of single-nucleotide polymorphisms. Biotechniques 2000;28:710-714.
6. Tyagi S, Bratu DP, Kramer FR. Multicolor molecular beacons for allele discrimination. Nat Biotechnol 1998;16:49-53. (Pubitemid 28035948)
7. Marras SA, Kramer FR, Tyagi S. Multiplex detection of single-nucleotide variations using molecular beacons. Genet Anal 1999;14:151-156. (Pubitemid 29095372)
8. Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989;17:2503-2516.
9. Okayama H, Curiel DT, Brantly ML, Holmes MD, Crystal RG. Rapid nonradioactive detection of mutations in the human genome by allele-specific amplification. J Lab Clin Med 1989;114:105-113. (Pubitemid 19212768)
10. Jeffreys AJ, MacLeod A, Tamaki K, Neil DL, Monckton DG. Minisatellite repeat coding as a digital approach to DNA typing. Nature 1991;354:204-209. (Pubitemid 21896812)
11. Lyamichev V, Mast AL, Hall JG, et al. Polymorphism identification and quantitative detection of genomic DNA by invasive cleavage of oligonucleotide probes. Nat Biotechnol 1999;17:292-296. (Pubitemid 29122638)
12. Howell WM, Jobs M, Gyllensten U, Brookes AJ. Dynamic allelespecific hybridization. A new method for scoring single nucleotide polymorphisms. Nat Biotechnol 1999;17:87-88.
13. Nyren P, Karamohamed S, Ronaghi M. Detection of single-base changes using a bioluminometric primer extension assay. Anal Biochem 1997;244:367-373. (Pubitemid 27043334)
14. Ahmadian A, Gharizadeh B, Gustafsson AC, et al. Single-nucleotide polymorphism analysis by pyrosequencing. Anal Biochem 2000;280:103-110.
15. Fan JB, Chen X, Halushka MK, et al. Parallel genotyping of human SNPs using generic high-density oligonucleotide tag arrays. Genome Res 2000;10:853-860. (Pubitemid 30433358)
16. Nollau P, Wagener C. Methods for detection of point mutations: Performance and quality assessment. IFCC Scientific Division, Committee on Molecular Biology Techniques. Clin Chem 1997;43:1114-1128.
17. Syvanen AC. From gels to chips: "Minisequencing" primer extension for analysis of point mutations and single nucleotide polymorphisms. Hum Mutat 1999;13:1-10.
18. Zhou G, Kamahori M, Okano K, Chuan G, Harada K, Kambara H. Quantitative detection of single nucleotide polymorphisms for a pooled sample by a bioluminometric assay coupled with modified primer extension reactions (BAMPER). Nucleic Acids Res 2001;29:E93.
19. Myakishev MV, Khripin Y, Hu S, Hamer DH. High-throughput SNP genotyping by allele-specific PCR with universal energy-transfer-labeled primers. Genome Res 2001;11:163-169. (Pubitemid 32117962)
20. Senafi SB, Clarke DJ, Burchell B. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucurono-syltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 1994;303:233-240. (Pubitemid 24302924)
21. Iyer L, King CD, Whitington PF, et al. Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes. J Clin Invest 1998;101:847-854. (Pubitemid 28096082)
22. Akaba K, Kimura T, Sasaki A, et al. Neonatal hyperbilirubinemia and mutation of the bilirubin uridine diphosphate-glucuronosyl-transferase gene: A common missense mutation among Japanese, Koreans and Chinese. Biochem Mol Biol Int 1998;46:21-26. (Pubitemid 28474694)
23. Aono S, Yamada Y, Keino H, et al. Identification of defect in the genes for bilirubin UDP-glucuronosyltransferase in a patient with Crigler-Najjar syndrome type II. Biochem Biophys Res Commun 1993;197:1239-1244. (Pubitemid 124009574)
24. Jinno H, Tanaka-Kagawa T, Hanioka N, et al. Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38), an active metabolite of irinotecan (CPT-11), by human UGT1A1 variants, G71R, P229Q, and Y486D. Drug Metab Dispos 2003;31:108-113. (Pubitemid 36735264)
25. Owens IS, Ritter JK. The novel bilirubin/phenol UDP- glucuronosyltransferase UGT1 gene locus: Implications for multiple nonhemolytic familial hyperbilirubinemia phenotypes. Pharmacogenetics 1992;2:93-108.
26. QIAamp DNA Mini Kit and QIAamp DNA Blood Mini Kit Handbook, 2003.
27. Hasegawa Y, Sarashina T, Ando M, et al. Rapid detection of UGT1A1 gene polymorphisms by newly developed Invader assay. Clin Chem 2004;50:479-480. (Pubitemid 38970674)
28. Yamamoto K, Sato H, Fujiyama Y, Doida Y, Bamba T. Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP-glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II. Biochem Biophys Acta 1998;406:267-273. (Pubitemid 28269309)
29. Maruo Y, Nishizawa K, Sato H, Doida Y, Shimada M. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics 1999;103:1224-1227. (Pubitemid 29258797)
30. Minami H, Sai K, Saeki M, et al. Irinotecan pharmacokinetics/ pharmacodynamics and UGT1A genetic polymorphisms in Japanese: Roles of UGT1A1*6 and *28. Pharmacogenet Genom 2007;17:497-504. (Pubitemid 46905216)
31. Saeki M, Saito Y, Jinno H, et al. Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing. Clin Chem 2003;49:1182-1185. (Pubitemid 36751107)
32. Sai K, Saeki M, Saito Y, et al. UGT1A1 haplotypes associated with reduced glucuronidation and increased serum bilirubin in irinotecan-administered Japanese patients with cancer. Clin Pharmacol Ther 2004;75:501-515. (Pubitemid 38746601)